Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
79.74
-2.73 (-3.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Vaxcyte Employees
Vaxcyte had 254 employees as of December 31, 2023. The number of employees increased by 96 or 60.76% compared to the previous year.
Employees
254
Change (1Y)
96
Growth (1Y)
60.76%
Revenue / Employee
n/a
Profits / Employee
-$1,998,614
Market Cap
9.94B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 254 | 96 | 60.76% |
Dec 31, 2022 | 158 | 69 | 77.53% |
Dec 31, 2021 | 89 | 31 | 53.45% |
Dec 31, 2020 | 58 | 15 | 34.88% |
Dec 31, 2019 | 43 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
PCVX News
- 9 days ago - Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewsWire
- 17 days ago - Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants - GlobeNewsWire
- 22 days ago - Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 22 days ago - Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm - GlobeNewsWire
- 5 weeks ago - Vaxcyte Aims To Outshine Pfizer With Bold VAX-31 Strategy - Seeking Alpha
- 2 months ago - Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants - GlobeNewsWire
- 3 months ago - Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - GlobeNewsWire
- 3 months ago - Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire